Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease

H van Andel; KA Kocemba; A de Haan-Kramer; CH Mellink; M Piwowar; A. Broijl; Mark van Duin; Pieter Sonneveld; MM Maurice; MJ Kersten; M Spaargaren; ST Pals

doi:10.1038/onc.2016.368

Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease

H van Andel, KA Kocemba, A de Haan-Kramer, CH Mellink, M Piwowar, A. Broijl, Mark van Duin, Pieter Sonneveld, MM Maurice, MJ Kersten, M Spaargaren, ST Pals

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

41 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2105-2115
Number of pages	11
Journal	Oncogene
Volume	36
Issue number	15
DOIs	https://doi.org/10.1038/onc.2016.368
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1038/onc.2016.368

http://hdl.handle.net/1765/108354

Cite this

@article{e14e318ebe40446eb64af9b98585d996,

title = "Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease",

author = "{van Andel}, H and KA Kocemba and {de Haan-Kramer}, A and CH Mellink and M Piwowar and A. Broijl and {van Duin}, Mark and Pieter Sonneveld and MM Maurice and MJ Kersten and M Spaargaren and ST Pals",

year = "2017",

doi = "10.1038/onc.2016.368",

language = "Undefined/Unknown",

volume = "36",

pages = "2105--2115",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Springer Nature",

number = "15",

}

TY - JOUR

T1 - Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease

AU - van Andel, H

AU - Kocemba, KA

AU - de Haan-Kramer, A

AU - Mellink, CH

AU - Piwowar, M

AU - Broijl, A.

AU - van Duin, Mark

AU - Sonneveld, Pieter

AU - Maurice, MM

AU - Kersten, MJ

AU - Spaargaren, M

AU - Pals, ST

PY - 2017

Y1 - 2017

U2 - 10.1038/onc.2016.368

DO - 10.1038/onc.2016.368

M3 - Article

SN - 0950-9232

VL - 36

SP - 2105

EP - 2115

JO - Oncogene

JF - Oncogene

IS - 15

ER -